VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,093,000 | +19.8% | 28,500 | 0.0% | 1.52% | +38.9% |
| Q4 2021 | $912,000 | +8.7% | 28,500 | 0.0% | 1.10% | -30.2% |
| Q3 2021 | $839,000 | -13.3% | 28,500 | 0.0% | 1.57% | -9.8% |
| Q2 2021 | $968,000 | -59.5% | 28,500 | -58.8% | 1.74% | -29.3% |
| Q1 2021 | $2,392,000 | +63.2% | 69,195 | +70.0% | 2.46% | -17.2% |
| Q4 2020 | $1,466,000 | -8.0% | 40,695 | 0.0% | 2.98% | -22.5% |
| Q3 2020 | $1,594,000 | -14.2% | 40,695 | -19.7% | 3.84% | -5.7% |
| Q2 2020 | $1,858,000 | +1.3% | 50,660 | -36.4% | 4.07% | +18.2% |
| Q1 2020 | $1,834,000 | -37.1% | 79,610 | -20.1% | 3.45% | +12.7% |
| Q4 2019 | $2,917,000 | +0.6% | 99,610 | -8.3% | 3.06% | -4.3% |
| Q3 2019 | $2,901,000 | +0.1% | 108,610 | -4.2% | 3.19% | -1.8% |
| Q2 2019 | $2,897,000 | +12.7% | 113,350 | -1.1% | 3.25% | +7.9% |
| Q1 2019 | $2,571,000 | +4.7% | 114,660 | -1.5% | 3.01% | -5.4% |
| Q4 2018 | $2,455,000 | – | 116,385 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |